Molly E Waring1, Kristin L Schneider2, Bradley M Appelhans3, Andrew M Busch4, Matthew C Whited5, Stephanie Rodrigues6, Stephenie C Lemon7, Sherry L Pagoto8. 1. Division of Epidemiology of Chronic Diseases and Vulnerable Populations, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: molly.waring@umassmed.edu. 2. Department of Psychology, Rosalind Franklin University, North Chicago, IL, United States. Electronic address: kristin.schneider@rosalindfranklin.edu. 3. Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, United States. Electronic address: brad_appelhans@rush.edu. 4. Department of Psychiatry & Human Behavior, Alpert Medical School of Brown University, Providence, RI, United States; Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, United States. Electronic address: andrew_busch@brown.edu. 5. Department of Psychology, East Carolina University, Greenville, NC, United States. Electronic address: whitedm@ecu.edu. 6. Division of Addiction, Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: stephanie.rodrigues@umassmed.edu. 7. Division of Behavioral and Preventive Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: stephenie.lemon@umassmed.edu. 8. Division of Behavioral and Preventive Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States. Electronic address: sherry.pagoto@umassmed.edu.
Abstract
OBJECTIVE: Some adults with comorbid depression and obesity respond well to lifestyle interventions while others have poor outcomes. The objective of this study was to evaluate whether early-treatment weight loss progress predicts clinically significant 6-month weight loss among women with obesity and depression. METHODS: We conducted a secondary analysis of data from 75 women with obesity and depression who received a standard lifestyle intervention. Relative risks (RRs) and 95% confidence intervals (CIs) for achieving ≥5% weight loss by 6 months were calculated based on whether they achieved ≥1 lb/week weight loss in weeks 2-8. Among those on target at week 3, we examined potential subsequent time points at which weight loss progress might identify additional individuals at risk for treatment failure. RESULTS: At week 2, women who averaged ≥1 lb/week loss were twice as likely to achieve 5% weight loss by 6 months than those who did not (RR=2.40; 95% CI: 2.32-4.29); weight loss at weeks 3-8 was similarly predictive (RRs=2.02-3.20). Examining weight loss progress at week 3 and subsequently at a time point during weeks 4-8, 52-67% of participants were not on target with their weight loss, and those on target were 2-3 times as likely to achieve 5% weight loss by 6 months (RRs=1.82-2.92). CONCLUSION: Weight loss progress as early as week 2 of treatment predicts weight loss outcomes for women with comorbid obesity and depression, which supports the feasibility of developing stepped care interventions that adjust treatment intensity based on early progress in this population.
OBJECTIVE: Some adults with comorbid depression and obesity respond well to lifestyle interventions while others have poor outcomes. The objective of this study was to evaluate whether early-treatment weight loss progress predicts clinically significant 6-month weight loss among women with obesity and depression. METHODS: We conducted a secondary analysis of data from 75 women with obesity and depression who received a standard lifestyle intervention. Relative risks (RRs) and 95% confidence intervals (CIs) for achieving ≥5% weight loss by 6 months were calculated based on whether they achieved ≥1 lb/week weight loss in weeks 2-8. Among those on target at week 3, we examined potential subsequent time points at which weight loss progress might identify additional individuals at risk for treatment failure. RESULTS: At week 2, women who averaged ≥1 lb/week loss were twice as likely to achieve 5% weight loss by 6 months than those who did not (RR=2.40; 95% CI: 2.32-4.29); weight loss at weeks 3-8 was similarly predictive (RRs=2.02-3.20). Examining weight loss progress at week 3 and subsequently at a time point during weeks 4-8, 52-67% of participants were not on target with their weight loss, and those on target were 2-3 times as likely to achieve 5% weight loss by 6 months (RRs=1.82-2.92). CONCLUSION:Weight loss progress as early as week 2 of treatment predicts weight loss outcomes for women with comorbid obesity and depression, which supports the feasibility of developing stepped care interventions that adjust treatment intensity based on early progress in this population.
Authors: John M Jakicic; Deborah F Tate; Wei Lang; Kelli K Davis; Kristen Polzien; Amy D Rickman; Karen Erickson; Rebecca H Neiberg; Eric A Finkelstein Journal: JAMA Date: 2012-06-27 Impact factor: 56.272
Authors: Robert A Carels; Lynn Darby; Holly M Cacciapaglia; Olivia M Douglass; Jessica Harper; Mary E Kaplar; Krista Konrad; Sofia Rydin; Karin Tonkin Journal: J Psychosom Res Date: 2005-12 Impact factor: 3.006
Authors: Rena R Wing; Richard F Hamman; George A Bray; Linda Delahanty; Sharon L Edelstein; James O Hill; Edward S Horton; Mary A Hoskin; Andrea Kriska; John Lachin; Elizabeth J Mayer-Davis; Xavier Pi-Sunyer; Judith G Regensteiner; Beth Venditti; Judith Wylie-Rosett Journal: Obes Res Date: 2004-09
Authors: Veronica Yank; Lan Xiao; Sandra R Wilson; Randall S Stafford; Lisa Goldman Rosas; Jun Ma Journal: Obesity (Silver Spring) Date: 2013-10-15 Impact factor: 5.002
Authors: Andrew M Busch; Matthew C Whited; Bradley M Appelhans; Kristin L Schneider; Molly E Waring; Michele A DeBiasse; Jessica L Oleski; Sybil L Crawford; Sherry L Pagoto Journal: Obesity (Silver Spring) Date: 2013-03 Impact factor: 5.002
Authors: Jie Liu; Job G Godino; Gregory J Norman; Linda Hill; Karen Calfas; James F Sallis; Elva Arredondo; Cheryl L Rock; Michael Criqui; Shu-Hong Zhu; Kenneth Griffiths; Jennifer Covin; Lindsay Dillon; Kevin Patrick Journal: Prev Med Date: 2018-07-25 Impact factor: 4.018
Authors: Ashley A Wiedemann; Sydney S Baumgardt; Valentina Ivezaj; Stephanie G Kerrigan; Janet A Lydecker; Carlos M Grilo; Rachel D Barnes Journal: Transl Behav Med Date: 2021-02-11 Impact factor: 3.046
Authors: Dina H Griauzde; Amal Othman; Chris Dallas; Lauren Oshman; Jonathan Gabison; Dorene S Markel; Caroline R Richardson; Jeffrey T Kullgren; Gretchen Piatt; Michele Heisler; Amy M Kilbourne; Andrew Kraftson Journal: Prim Health Care Res Dev Date: 2022-03-02 Impact factor: 1.458